Pregnancy comes with plenty of plot twists: cravings, heartburn, a suddenly heroic sense of smell, and an impressive ability to Google medical questions at 2:13 a.m. If you use Dupixent, also known by its generic name dupilumab, one big question may rise to the top: “Can I keep taking it while pregnant or breastfeeding?”

The honest answer is not a dramatic yes or no. Dupixent is a prescription biologic used for several inflammatory conditions, including moderate-to-severe atopic dermatitis, certain types of asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, chronic spontaneous urticaria, chronic obstructive pulmonary disease with an eosinophilic phenotype, bullous pemphigoid, and allergic fungal rhinosinusitis. Because these conditions can affect sleep, breathing, nutrition, skin integrity, and daily functioning, the decision to continue or pause treatment during pregnancy should be personal, medical, and made with the right teamnot decided by panic-scrolling.

This guide explains what is currently known about Dupixent and pregnancy, breastfeeding, fertility, vaccines, side effects, and practical planning. Think of it as a calm, well-organized conversation starter for your dermatologist, allergist, pulmonologist, gastroenterologist, OB-GYN, or maternal-fetal medicine specialist.

What Is Dupixent?

Dupixent is a biologic medication that targets inflammation related to interleukin-4 and interleukin-13 signaling. In plain English, it helps calm specific immune pathways involved in type 2 inflammation. That type of inflammation can play a major role in eczema, asthma, nasal polyps, eosinophilic esophagitis, and other allergic or inflammatory conditions.

Unlike a steroid, Dupixent does not broadly suppress the entire immune system. Instead, it works more selectively. It is given as a subcutaneous injection, meaning the medicine is injected under the skin. Depending on the condition being treated, a person may take it every week, every two weeks, or every four weeks.

For many patients, Dupixent is not a “nice little bonus” medication. It can be the treatment that finally helps control severe itching, repeated asthma flares, blocked sinuses, swallowing symptoms, or painful skin nodules. That matters during pregnancy because untreated or poorly controlled disease can also carry risk.

Can You Take Dupixent During Pregnancy?

Current prescribing information says available data from case reports and case series have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. That is reassuring, but it does not mean researchers have unlimited pregnancy data. Pregnant people are often excluded from clinical trials, so much of what clinicians know comes from real-world reports, registries, case series, and expert judgment.

Dupixent is a monoclonal antibody, and human IgG antibodies can cross the placenta. Placental transfer generally increases as pregnancy progresses and is highest in the third trimester. This means a baby may be exposed to some Dupixent before birth, especially later in pregnancy. The known question is not simply “Can transfer happen?” but “What does that transfer mean clinically?” At this time, the full answer is still developing.

Animal data included in the prescribing information did not show adverse developmental effects in offspring after exposure to a related antibody during pregnancy. Human reports so far are also generally reassuring, but the evidence base remains smaller than anyone would like. Translation: the data do not wave a red flag, but they also do not give clinicians a giant foam finger that says “zero risk.”

Why the Underlying Condition Matters

When thinking about Dupixent in pregnancy, it is easy to focus only on the medicine. But the condition being treated deserves equal attention. Severe eczema can lead to relentless itching, poor sleep, open skin, infection risk, stress, and reduced quality of life. Moderate-to-severe asthma can affect oxygen levels and may increase the chance of complications if it is poorly controlled. Eosinophilic esophagitis can make eating difficult. Chronic sinus disease can turn breathing and sleeping into a nightly obstacle course.

For asthma in particular, control during pregnancy is important. Poorly or moderately controlled asthma has been associated with higher risks such as preeclampsia, preterm birth, low birth weight, and babies being small for gestational age. If stopping Dupixent leads to flares that require oral steroids, emergency care, or repeated infections, that risk must be considered too.

That is why the best conversation is not “Is Dupixent safe?” in isolation. A more useful question is: “For my diagnosis, severity, history of flares, past treatment failures, pregnancy stage, and available alternatives, is continuing Dupixent likely to offer more benefit than risk?”

Dupixent and Trying to Conceive

If you are planning pregnancy, do not wait until the positive test to start the discussion. Bring it up early, ideally before trying to conceive. Your healthcare provider may review how stable your condition has been, how long you have been on Dupixent, what happened when you used other treatments, and whether your disease tends to flare when medications change.

Some people may be advised to continue Dupixent while trying to conceive because stable disease is the priority. Others may consider a medication plan adjustment before pregnancy. There is no universal rule that fits every patient, which is inconvenient but very on-brand for biology.

It is also worth asking about timing. Because Dupixent remains in the body for a period after each dose, stopping it right before conception does not mean the medication instantly disappears. Your clinician can explain what that means for your situation and whether any change is actually useful.

Dupixent and Fertility

There is no strong evidence that Dupixent harms fertility in women or men. However, people taking Dupixent often have chronic inflammatory conditions, and those conditions can affect sleep, stress, energy, sexual comfort, and overall health. In other words, fertility planning should look at the whole person, not just the medication list.

If you are undergoing fertility treatment, tell both your fertility specialist and the doctor who prescribes Dupixent. They can coordinate timing, monitor symptoms, and avoid last-minute surprises. Fertility care already has enough acronyms; your medication plan should not be another mystery abbreviation in the folder.

What If You Become Pregnant While Taking Dupixent?

First, do not panic. Second, do not stop Dupixent abruptly without medical advice. Contact the clinician who prescribes it and your pregnancy care provider. They may want to review your diagnosis, current dose, trimester, symptom control, and previous flare history.

Your provider may also discuss pregnancy exposure reporting or registry options. Pregnancy registries collect information about medication exposure and pregnancy outcomes to help improve future guidance. Participation can be valuable because it helps turn today’s uncertainty into tomorrow’s better answers.

Can You Breastfeed While Taking Dupixent?

Breastfeeding guidance for Dupixent is cautious but increasingly reassuring. Dupixent is a large protein molecule, so the amount expected to pass into breast milk is likely low. Even if a small amount enters breast milk, it would probably be broken down in the baby’s digestive tract, especially in older infants. That said, official prescribing information states that there are no definitive data on the presence of dupilumab in human milk, its effects on a breastfed infant, or its effects on milk production.

Expert references generally consider Dupixent compatible or acceptable during breastfeeding in many situations, especially when the mother has a clear clinical need. Extra caution may be reasonable with newborns, premature infants, or medically fragile babies. Some experts suggest waiting at least two weeks after delivery before resuming treatment when possible, as this may reduce early transfer during the immediate newborn period.

The best breastfeeding decision balances three things: the benefits of breastfeeding, the mother’s need for disease control, and any possible risk to the infant. A parent with severe eczema who cannot sleep, has cracked infected skin, and is spiraling into misery may need a different plan than someone with mild symptoms controlled by moisturizers and occasional topical therapy.

Possible Side Effects to Watch For

Dupixent can cause side effects whether or not you are pregnant or breastfeeding. Commonly discussed issues include injection site reactions, eye problems such as conjunctivitis or keratitis, oral herpes, dry eye, eosinophilia, joint pain, and certain skin reactions. People using Dupixent should report new or worsening eye symptoms, vision changes, persistent redness, or eye pain.

Patients should also tell their provider about symptoms that could suggest an allergic reaction, such as swelling, rash, breathing trouble, dizziness, or severe itching after an injection. Rare but serious reactions require prompt medical care.

If you are using Dupixent for asthma, remember that it is not a rescue medication. It should not be used to treat sudden breathing attacks. Keep your rescue inhaler and asthma action plan exactly as directed by your clinician. Pregnancy is not the time to freelance your way through wheezing.

Vaccines, Infections, and Pregnancy Planning

The prescribing information advises considering completion of age-appropriate vaccinations before starting Dupixent and avoiding live vaccines during treatment. During pregnancy, vaccine planning can already be specific, so tell your OB-GYN and prescribing specialist that you use Dupixent before receiving any vaccine.

Dupixent labeling also notes that pre-existing parasitic worm infections should be treated before starting therapy. If a helminth infection occurs during treatment and does not respond to anti-parasitic therapy, Dupixent may need to be paused until the infection resolves. This is not an everyday issue for most people in the United States, but it matters if you have relevant travel, exposure, or symptoms.

Questions to Ask Your Doctor

Before pregnancy, during pregnancy, or while breastfeeding, bring a practical list of questions to your appointment. Good questions include:

• How severe is my condition if I stop Dupixent?
• Have I failed safer or better-studied options?
• What are the risks of a flare during pregnancy?
• Should my dose schedule change?
• Do I need a maternal-fetal medicine consult?
• Should I join a pregnancy exposure registry?
• How should we handle newborn vaccines if there was third-trimester exposure?
• Is breastfeeding appropriate in my case?
• What symptoms should make me call immediately?

These questions help move the conversation away from fear and toward a real plan. A good plan is not always glamorous, but it is deeply underrated. So is remembering to write down what your doctor says, because pregnancy brain has been known to delete files without warning.

Dupixent Alternatives During Pregnancy

Alternatives depend entirely on the condition being treated. For atopic dermatitis, pregnancy-friendly strategies may include fragrance-free moisturizers, trigger avoidance, wet wraps, certain topical corticosteroids used appropriately, topical calcineurin inhibitors in selected cases, phototherapy, and infection management when needed. For asthma, inhaled therapies and asthma action plans are often central. For nasal polyps, saline rinses, intranasal corticosteroids, and specialist care may be considered. For eosinophilic esophagitis, dietary therapy and other medications may be discussed.

However, “alternative” does not automatically mean safer, stronger, or more effective. Some options have better pregnancy data but may not control severe disease. Others may carry their own risks. The right plan should be individualized rather than built from internet vibes and a half-finished cup of ginger tea.

Practical Tips for Using Dupixent During Pregnancy

If your care team recommends continuing Dupixent, create a simple tracking system. Record your injection dates, symptom changes, flares, side effects, and any missed doses. Keep photos of skin flares if you have eczema, track peak flow or symptoms if you have asthma, and note swallowing issues if you have eosinophilic esophagitis.

Store Dupixent exactly as directed and make sure you understand how long it can remain at room temperature before use. If nausea, fatigue, a growing belly, or general third-trimester acrobatics make self-injection harder, ask whether a partner, caregiver, or nurse can help.

Also keep every member of your care team in the loop. Your OB-GYN should know about Dupixent. Your baby’s pediatrician should know if there was third-trimester exposure. Your prescribing specialist should know if pregnancy symptoms, infections, or new medications enter the picture.

Real-Life Experience: What Patients Often Worry About

Many people describe the emotional side of Dupixent and pregnancy as a tug-of-war. On one side is the desire to protect the baby from any unnecessary exposure. On the other side is the memory of what life was like before the medication worked: nights spent scratching until sheets looked like a crime scene, asthma flares that sent everyone searching for the rescue inhaler, sinus pressure that made every morning feel like waking up inside a balloon, or food getting stuck because eosinophilic esophagitis was not exactly in a cooperative mood.

One common experience is guilt. A pregnant person may think, “If I take this medication, am I being selfish?” But needing treatment is not selfish. Breathing well, sleeping, eating, avoiding infections, and staying functional are part of a healthy pregnancy. A parent’s health is not a side quest. It is central to the story.

Another common experience is confusion, because different clinicians may sound slightly different. A dermatologist may focus on skin control. An OB-GYN may focus on pregnancy data. An allergist may focus on asthma or nasal polyps. A pediatrician may ask about infant exposure and vaccines. That does not mean anyone is wrong; it means the decision has several angles. The most helpful step is often asking your doctors to communicate directly or asking for a shared plan in writing.

Some patients also worry about breastfeeding. They may feel pressure to breastfeed, pressure not to take medication, and pressure to look serene while doing both. In real life, breastfeeding decisions are rarely that tidy. If Dupixent keeps a parent’s disease controlled and breastfeeding is otherwise going well, a clinician may feel comfortable with continued treatment. If the baby is premature or medically fragile, the conversation may be more cautious. If breastfeeding worsens exhaustion or delays needed care, formula or combination feeding can also be a healthy choice. The baby needs nourishment; the parent needs care; nobody needs a guilt casserole.

Patients who continue Dupixent through pregnancy often say the most reassuring thing is having a plan. That plan may include scheduled check-ins, symptom tracking, clear instructions for flares, vaccine discussions, and a postpartum strategy. The postpartum period deserves special attention because sleep deprivation, hormonal shifts, skin changes, stress, and feeding demands can all stir the inflammatory pot. Having Dupixent decisions settled before delivery can prevent frantic decision-making when everyone is tired and the baby has decided that 3 a.m. is a wonderful time for jazz hands.

Finally, many people find comfort in remembering that medical decisions during pregnancy are almost never about perfect certainty. They are about the best available evidence, the seriousness of the condition, safer alternatives when available, and the patient’s values. Dupixent may be the right choice for one pregnancy and not the right choice for another. That is not inconsistency; that is individualized care doing its job.

Conclusion

Dupixent during pregnancy and breastfeeding is a topic that calls for nuance, not panic. Current data from reports, case series, expert resources, and prescribing information are generally reassuring, but pregnancy and lactation data remain limited. Because Dupixent can cross the placenta, especially later in pregnancy, and because official labeling does not provide a blanket guarantee for breastfeeding, decisions should be made with a knowledgeable healthcare team.

The key is balance. For some people, continuing Dupixent may help prevent serious flares, protect breathing, improve sleep, and reduce the need for other medications. For others, pausing or switching may make sense. The right answer depends on the condition being treated, symptom severity, trimester, infant factors, previous treatment history, and personal comfort.

If you are pregnant, planning pregnancy, or breastfeeding while using Dupixent, talk with your clinician before making changes. A thoughtful plan can help protect both parent and babyand it is far better than letting the internet make medical decisions while wearing pajamas and holding a sleeve of crackers.